The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Oncology Market Research Report 2025
Synopsis
Veterinary oncology is a subspecialty of veterinary medicine that deals with cancer diagnosis and treatment in animals.
The global Veterinary Oncology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 115%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Oncology.
Report Scope
The Veterinary Oncology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PetCure Oncology
Accuray Incorporated
Varian Medical Systems
Boehringer Ingelheim
Elanco
Zoetis Karyopharm Therapeutics, Inc.
One Health
Regeneus Ltd.
Nippon Zenyaku Kogyo Co., Ltd.
Morphogenesis, Inc.
Karyopharm Therapeutics, Inc.
Segment by Type
Surgery
Radiology
Chemotherapy
Immunotherapy
Others (Combination Therapy, Targeted Therapy)
Segment by Application
Canine
Feline
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Oncology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Veterinary oncology is a subspecialty of veterinary medicine that deals with cancer diagnosis and treatment in animals.
The global Veterinary Oncology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 115%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Oncology.
Report Scope
The Veterinary Oncology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PetCure Oncology
Accuray Incorporated
Varian Medical Systems
Boehringer Ingelheim
Elanco
Zoetis Karyopharm Therapeutics, Inc.
One Health
Regeneus Ltd.
Nippon Zenyaku Kogyo Co., Ltd.
Morphogenesis, Inc.
Karyopharm Therapeutics, Inc.
Segment by Type
Surgery
Radiology
Chemotherapy
Immunotherapy
Others (Combination Therapy, Targeted Therapy)
Segment by Application
Canine
Feline
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Oncology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Oncology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgery
1.2.3 Radiology
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Others (Combination Therapy, Targeted Therapy)
1.3 Market by Application
1.3.1 Global Veterinary Oncology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Canine
1.3.3 Feline
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Oncology Market Perspective (2019-2030)
2.2 Veterinary Oncology Growth Trends by Region
2.2.1 Global Veterinary Oncology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Veterinary Oncology Historic Market Size by Region (2019-2024)
2.2.3 Veterinary Oncology Forecasted Market Size by Region (2025-2030)
2.3 Veterinary Oncology Market Dynamics
2.3.1 Veterinary Oncology Industry Trends
2.3.2 Veterinary Oncology Market Drivers
2.3.3 Veterinary Oncology Market Challenges
2.3.4 Veterinary Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Oncology Players by Revenue
3.1.1 Global Top Veterinary Oncology Players by Revenue (2019-2024)
3.1.2 Global Veterinary Oncology Revenue Market Share by Players (2019-2024)
3.2 Global Veterinary Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Oncology Revenue
3.4 Global Veterinary Oncology Market Concentration Ratio
3.4.1 Global Veterinary Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Oncology Revenue in 2023
3.5 Veterinary Oncology Key Players Head office and Area Served
3.6 Key Players Veterinary Oncology Product Solution and Service
3.7 Date of Enter into Veterinary Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Oncology Breakdown Data by Type
4.1 Global Veterinary Oncology Historic Market Size by Type (2019-2024)
4.2 Global Veterinary Oncology Forecasted Market Size by Type (2025-2030)
5 Veterinary Oncology Breakdown Data by Application
5.1 Global Veterinary Oncology Historic Market Size by Application (2019-2024)
5.2 Global Veterinary Oncology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Veterinary Oncology Market Size (2019-2030)
6.2 North America Veterinary Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Veterinary Oncology Market Size by Country (2019-2024)
6.4 North America Veterinary Oncology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Oncology Market Size (2019-2030)
7.2 Europe Veterinary Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Veterinary Oncology Market Size by Country (2019-2024)
7.4 Europe Veterinary Oncology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Oncology Market Size (2019-2030)
8.2 Asia-Pacific Veterinary Oncology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Veterinary Oncology Market Size by Region (2019-2024)
8.4 Asia-Pacific Veterinary Oncology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Oncology Market Size (2019-2030)
9.2 Latin America Veterinary Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Veterinary Oncology Market Size by Country (2019-2024)
9.4 Latin America Veterinary Oncology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Oncology Market Size (2019-2030)
10.2 Middle East & Africa Veterinary Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Veterinary Oncology Market Size by Country (2019-2024)
10.4 Middle East & Africa Veterinary Oncology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PetCure Oncology
11.1.1 PetCure Oncology Company Detail
11.1.2 PetCure Oncology Business Overview
11.1.3 PetCure Oncology Veterinary Oncology Introduction
11.1.4 PetCure Oncology Revenue in Veterinary Oncology Business (2019-2024)
11.1.5 PetCure Oncology Recent Development
11.2 Accuray Incorporated
11.2.1 Accuray Incorporated Company Detail
11.2.2 Accuray Incorporated Business Overview
11.2.3 Accuray Incorporated Veterinary Oncology Introduction
11.2.4 Accuray Incorporated Revenue in Veterinary Oncology Business (2019-2024)
11.2.5 Accuray Incorporated Recent Development
11.3 Varian Medical Systems
11.3.1 Varian Medical Systems Company Detail
11.3.2 Varian Medical Systems Business Overview
11.3.3 Varian Medical Systems Veterinary Oncology Introduction
11.3.4 Varian Medical Systems Revenue in Veterinary Oncology Business (2019-2024)
11.3.5 Varian Medical Systems Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Veterinary Oncology Introduction
11.4.4 Boehringer Ingelheim Revenue in Veterinary Oncology Business (2019-2024)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Elanco
11.5.1 Elanco Company Detail
11.5.2 Elanco Business Overview
11.5.3 Elanco Veterinary Oncology Introduction
11.5.4 Elanco Revenue in Veterinary Oncology Business (2019-2024)
11.5.5 Elanco Recent Development
11.6 Zoetis Karyopharm Therapeutics, Inc.
11.6.1 Zoetis Karyopharm Therapeutics, Inc. Company Detail
11.6.2 Zoetis Karyopharm Therapeutics, Inc. Business Overview
11.6.3 Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Introduction
11.6.4 Zoetis Karyopharm Therapeutics, Inc. Revenue in Veterinary Oncology Business (2019-2024)
11.6.5 Zoetis Karyopharm Therapeutics, Inc. Recent Development
11.7 One Health
11.7.1 One Health Company Detail
11.7.2 One Health Business Overview
11.7.3 One Health Veterinary Oncology Introduction
11.7.4 One Health Revenue in Veterinary Oncology Business (2019-2024)
11.7.5 One Health Recent Development
11.8 Regeneus Ltd.
11.8.1 Regeneus Ltd. Company Detail
11.8.2 Regeneus Ltd. Business Overview
11.8.3 Regeneus Ltd. Veterinary Oncology Introduction
11.8.4 Regeneus Ltd. Revenue in Veterinary Oncology Business (2019-2024)
11.8.5 Regeneus Ltd. Recent Development
11.9 Nippon Zenyaku Kogyo Co., Ltd.
11.9.1 Nippon Zenyaku Kogyo Co., Ltd. Company Detail
11.9.2 Nippon Zenyaku Kogyo Co., Ltd. Business Overview
11.9.3 Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Introduction
11.9.4 Nippon Zenyaku Kogyo Co., Ltd. Revenue in Veterinary Oncology Business (2019-2024)
11.9.5 Nippon Zenyaku Kogyo Co., Ltd. Recent Development
11.10 Morphogenesis, Inc.
11.10.1 Morphogenesis, Inc. Company Detail
11.10.2 Morphogenesis, Inc. Business Overview
11.10.3 Morphogenesis, Inc. Veterinary Oncology Introduction
11.10.4 Morphogenesis, Inc. Revenue in Veterinary Oncology Business (2019-2024)
11.10.5 Morphogenesis, Inc. Recent Development
11.11 Karyopharm Therapeutics, Inc.
11.11.1 Karyopharm Therapeutics, Inc. Company Detail
11.11.2 Karyopharm Therapeutics, Inc. Business Overview
11.11.3 Karyopharm Therapeutics, Inc. Veterinary Oncology Introduction
11.11.4 Karyopharm Therapeutics, Inc. Revenue in Veterinary Oncology Business (2019-2024)
11.11.5 Karyopharm Therapeutics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Veterinary Oncology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Surgery
Table 3. Key Players of Radiology
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Others (Combination Therapy, Targeted Therapy)
Table 7. Global Veterinary Oncology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Veterinary Oncology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Veterinary Oncology Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Veterinary Oncology Market Share by Region (2019-2024)
Table 11. Global Veterinary Oncology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Veterinary Oncology Market Share by Region (2025-2030)
Table 13. Veterinary Oncology Market Trends
Table 14. Veterinary Oncology Market Drivers
Table 15. Veterinary Oncology Market Challenges
Table 16. Veterinary Oncology Market Restraints
Table 17. Global Veterinary Oncology Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Veterinary Oncology Market Share by Players (2019-2024)
Table 19. Global Top Veterinary Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Oncology as of 2023)
Table 20. Ranking of Global Top Veterinary Oncology Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Veterinary Oncology Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Veterinary Oncology Product Solution and Service
Table 24. Date of Enter into Veterinary Oncology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Veterinary Oncology Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Veterinary Oncology Revenue Market Share by Type (2019-2024)
Table 28. Global Veterinary Oncology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Veterinary Oncology Revenue Market Share by Type (2025-2030)
Table 30. Global Veterinary Oncology Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Veterinary Oncology Revenue Market Share by Application (2019-2024)
Table 32. Global Veterinary Oncology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Veterinary Oncology Revenue Market Share by Application (2025-2030)
Table 34. North America Veterinary Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Veterinary Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Veterinary Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Veterinary Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Veterinary Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Veterinary Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Veterinary Oncology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Veterinary Oncology Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Veterinary Oncology Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Veterinary Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Veterinary Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Veterinary Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Veterinary Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Veterinary Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Veterinary Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 49. PetCure Oncology Company Detail
Table 50. PetCure Oncology Business Overview
Table 51. PetCure Oncology Veterinary Oncology Product
Table 52. PetCure Oncology Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 53. PetCure Oncology Recent Development
Table 54. Accuray Incorporated Company Detail
Table 55. Accuray Incorporated Business Overview
Table 56. Accuray Incorporated Veterinary Oncology Product
Table 57. Accuray Incorporated Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 58. Accuray Incorporated Recent Development
Table 59. Varian Medical Systems Company Detail
Table 60. Varian Medical Systems Business Overview
Table 61. Varian Medical Systems Veterinary Oncology Product
Table 62. Varian Medical Systems Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 63. Varian Medical Systems Recent Development
Table 64. Boehringer Ingelheim Company Detail
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim Veterinary Oncology Product
Table 67. Boehringer Ingelheim Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 68. Boehringer Ingelheim Recent Development
Table 69. Elanco Company Detail
Table 70. Elanco Business Overview
Table 71. Elanco Veterinary Oncology Product
Table 72. Elanco Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 73. Elanco Recent Development
Table 74. Zoetis Karyopharm Therapeutics, Inc. Company Detail
Table 75. Zoetis Karyopharm Therapeutics, Inc. Business Overview
Table 76. Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Product
Table 77. Zoetis Karyopharm Therapeutics, Inc. Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 78. Zoetis Karyopharm Therapeutics, Inc. Recent Development
Table 79. One Health Company Detail
Table 80. One Health Business Overview
Table 81. One Health Veterinary Oncology Product
Table 82. One Health Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 83. One Health Recent Development
Table 84. Regeneus Ltd. Company Detail
Table 85. Regeneus Ltd. Business Overview
Table 86. Regeneus Ltd. Veterinary Oncology Product
Table 87. Regeneus Ltd. Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 88. Regeneus Ltd. Recent Development
Table 89. Nippon Zenyaku Kogyo Co., Ltd. Company Detail
Table 90. Nippon Zenyaku Kogyo Co., Ltd. Business Overview
Table 91. Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Product
Table 92. Nippon Zenyaku Kogyo Co., Ltd. Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 93. Nippon Zenyaku Kogyo Co., Ltd. Recent Development
Table 94. Morphogenesis, Inc. Company Detail
Table 95. Morphogenesis, Inc. Business Overview
Table 96. Morphogenesis, Inc. Veterinary Oncology Product
Table 97. Morphogenesis, Inc. Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 98. Morphogenesis, Inc. Recent Development
Table 99. Karyopharm Therapeutics, Inc. Company Detail
Table 100. Karyopharm Therapeutics, Inc. Business Overview
Table 101. Karyopharm Therapeutics, Inc. Veterinary Oncology Product
Table 102. Karyopharm Therapeutics, Inc. Revenue in Veterinary Oncology Business (2019-2024) & (US$ Million)
Table 103. Karyopharm Therapeutics, Inc. Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Oncology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Veterinary Oncology Market Share by Type: 2023 VS 2030
Figure 3. Surgery Features
Figure 4. Radiology Features
Figure 5. Chemotherapy Features
Figure 6. Immunotherapy Features
Figure 7. Others (Combination Therapy, Targeted Therapy) Features
Figure 8. Global Veterinary Oncology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Veterinary Oncology Market Share by Application: 2023 VS 2030
Figure 10. Canine Case Studies
Figure 11. Feline Case Studies
Figure 12. Veterinary Oncology Report Years Considered
Figure 13. Global Veterinary Oncology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Veterinary Oncology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Veterinary Oncology Market Share by Region: 2023 VS 2030
Figure 16. Global Veterinary Oncology Market Share by Players in 2023
Figure 17. Global Top Veterinary Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Oncology as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Veterinary Oncology Revenue in 2023
Figure 19. North America Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Veterinary Oncology Market Share by Country (2019-2030)
Figure 21. United States Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Veterinary Oncology Market Share by Country (2019-2030)
Figure 25. Germany Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Veterinary Oncology Market Share by Region (2019-2030)
Figure 33. China Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Veterinary Oncology Market Share by Country (2019-2030)
Figure 41. Mexico Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Veterinary Oncology Market Share by Country (2019-2030)
Figure 45. Turkey Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Veterinary Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. PetCure Oncology Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 48. Accuray Incorporated Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 49. Varian Medical Systems Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 51. Elanco Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 52. Zoetis Karyopharm Therapeutics, Inc. Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 53. One Health Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 54. Regeneus Ltd. Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 55. Nippon Zenyaku Kogyo Co., Ltd. Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 56. Morphogenesis, Inc. Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 57. Karyopharm Therapeutics, Inc. Revenue Growth Rate in Veterinary Oncology Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
